Literature DB >> 11014442

Carotid stenting and "extarterectomy" in the management of head and neck cancer involving the internal carotid artery: technical case report.

E S Nussbaum1, S C Levine, D Hamlar, M T Madison.   

Abstract

OBJECTIVE AND IMPORTANCE: Head and neck cancer that invades the internal carotid artery (ICA) represents a significant management challenge. We describe a novel technique that allows for aggressive tumor removal without disrupting blood flow through the affected ICA. CLINICAL
PRESENTATION: A 62-year-old man was referred to our institution for management of a neck malignancy involving the ICA. Cerebral angiography suggested that there was good collateral flow from the opposite hemisphere, but the patient reported visual loss in the ipsilateral eye during balloon test occlusion of the ICA. INTERVENTION: A self-expanding stent was deployed in the ICA; it spanned the entire length of the artery involved by tumor. One month later, the patient underwent tumor resection. During surgery, a long ICA arteriotomy was performed directly down to the mesh of the stent. A neoendothelium had formed within the stent, which prevented arterial bleeding. The carotid wall was dissected from the stent without difficulty and removed en bloc with the surrounding tumor. The exposed stent was wrapped circumferentially with a synthetic patch material. The patient tolerated the procedure well, and postoperative angiography demonstrated normal filling of the ICA.
CONCLUSION: We describe a novel approach to a patient with head and neck cancer involving the cervical ICA. Preliminary stenting, which allows time for endothelialization before surgery, may permit aggressive tumor resection without interrupting flow through the ICA. This technique obviates the need for complicated carotid reconstruction procedures and avoids the risk of delayed ischemia from carotid sacrifice.

Entities:  

Mesh:

Year:  2000        PMID: 11014442     DOI: 10.1097/00006123-200010000-00041

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  Combined endovascular-surgical management of the internal carotid artery in complex tympanojugular paragangliomas.

Authors:  Mario Sanna; Paolo Piazza; Giuseppe De Donato; Roberto Menozzi; Maurizio Falcioni
Journal:  Skull Base       Date:  2009-01

2.  The use of internal carotid artery stenting in management of bilateral carotid body tumors.

Authors:  Masaya Konishi; Paolo Piazza; Seung-Ho Shin; Shailendra Sivalingam; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-04       Impact factor: 2.503

3.  Preoperative Protective Endovascular Covered Stent Placement Followed by Surgery for Management of the Cervical Common and Internal Carotid Arteries with Tumor Encasement.

Authors:  Michael R Markiewicz; Phillip Pirgousis; Curtis Bryant; James C Cunningham; Roi Dagan; Sukhwinder J Sandhu; Daniel A Siragusa; Arun Gopinath; Rui Fernandes
Journal:  J Neurol Surg B Skull Base       Date:  2016-06-20

4.  "Extarterectomy" for tumors invading the carotid artery: an animal model.

Authors:  Kazım Oner; Cem Bilgen; Ismail Oran; Tayfun Kirazli; Ahmet Memiş; Izzet Ovül; Ozlem Yilmaz
Journal:  Skull Base       Date:  2007-07

5.  Carotid body tumor resection utilizing a covered stent graft to enable resection of the tumor en bloc with the internal carotid artery.

Authors:  Mohammad Alqaim; Ajit S Puri; Alec E Vaezi; Andres Schanzer
Journal:  J Vasc Surg Cases Innov Tech       Date:  2019-11-13

6.  Carotid paragangliomas. Alternatives for presurgical endovascular management.

Authors:  Angelica Maria Ruiz Gaviria; Edison Ernesto Nuñez Ovaez; Carlos Alberto Saldivar Rodea; Aldo Fabrizio Santini Sanchez
Journal:  Radiol Case Rep       Date:  2022-08-05

7.  Management of Recurrent or Progressing Skull Base Chondrosarcomas: Predictors of Long-Term Outcomes.

Authors:  Jonathan D Breshears; Franco DeMonte; Ahmed Habib; Paul W Gidley; Shaan M Raza
Journal:  J Neurol Surg B Skull Base       Date:  2020-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.